INTEL CORP Income Taxes Disclosure
| Note 8 : | Income Taxes | ||||
| Years Ended ($ In Millions) | Dec 27, 2025 | Dec 28, 2024 | Dec 30, 2023 | |||||||||||||||||
Income (losses) before taxes: | ||||||||||||||||||||
U.S. | $ | (3,231) | $ | (13,450) | $ | (4,749) | ||||||||||||||
Non-U.S. | 4,788 | 2,241 | 5,511 | |||||||||||||||||
| Total income before taxes | $ | 1,557 | $ | (11,210) | $ | 762 | ||||||||||||||
| Provision for (benefit from) taxes: | ||||||||||||||||||||
| Current: | ||||||||||||||||||||
| Federal | $ | 310 | $ | 600 | $ | 538 | ||||||||||||||
| State | (18) | (8) | 23 | |||||||||||||||||
Non-U.S. | 910 | 1,364 | 535 | |||||||||||||||||
| Total current provision for (benefit from) taxes | 1,202 | 1,956 | 1,096 | |||||||||||||||||
| Deferred: | ||||||||||||||||||||
| Federal | 245 | 6,192 | (2,048) | |||||||||||||||||
| State | (11) | 67 | (21) | |||||||||||||||||
Non-U.S. | 95 | (192) | 60 | |||||||||||||||||
| Total deferred provision for (benefit from) taxes | 329 | 6,067 | (2,009) | |||||||||||||||||
| Total provision for (benefit from) taxes | $ | 1,531 | $ | 8,023 | $ | (913) | ||||||||||||||
| Effective tax rate | 98.3 | % | 71.6 | % | (119.8) | % | ||||||||||||||
| Dec 27, 2025 | ||||||||||||||
| Year Ended ($ In Millions) | Amount | Percent | ||||||||||||
| U.S. federal statutory tax | $ | 327 | 21.0 | % | ||||||||||
| State and local income tax, net of federal income tax effect | (23) | (1.5) | % | |||||||||||
| Foreign tax effects: | ||||||||||||||
| China: | ||||||||||||||
| Withholding tax | 314 | 20.2 | % | |||||||||||
| Other adjustments | (51) | (3.3) | % | |||||||||||
| Other foreign jurisdictions | (205) | (13.2) | % | |||||||||||
| Effects of cross-border tax laws: | ||||||||||||||
| Subpart F income inclusion | 248 | 15.9 | % | |||||||||||
| Foreign tax credit | (707) | (45.4) | % | |||||||||||
| Other | 145 | 9.3 | % | |||||||||||
| Tax credits: | ||||||||||||||
| Research and development credit | (977) | (62.7) | % | |||||||||||
| Changes in valuation allowances | 2,629 | 168.9 | % | |||||||||||
| Nontaxable or nondeductible items: | ||||||||||||||
| Share-based compensation | 120 | 7.7 | % | |||||||||||
| Altera divestiture and deconsolidation | (1,357) | (87.2) | % | |||||||||||
| Mark to market on equity securities | 377 | 24.2 | % | |||||||||||
| Other | 97 | 6.2 | % | |||||||||||
| Changes in unrecognized tax benefits | 334 | 21.5 | % | |||||||||||
| Other adjustments | 260 | 16.7 | % | |||||||||||
| Global effective tax | $ | 1,531 | 98.3 | % | ||||||||||
Years Ended | Dec 28, 2024 | Dec 30, 2023 | ||||||||||||
Expected provision (benefit) at statutory federal income tax rate | (21.0) | % | 21.0 | % | ||||||||||
| Increase (reduction) in rate resulting from: | ||||||||||||||
Federal valuation allowance | 93.2 | — | ||||||||||||
Goodwill impairment | 2.1 | — | ||||||||||||
Share-based compensation | 4.2 | 34.3 | ||||||||||||
| Unrecognized tax benefits and settlements | 1.3 | 16.3 | ||||||||||||
Non-U.S. income taxed at different rates | (5.3) | (60.6) | ||||||||||||
| Research and development tax credits | (5.6) | (99.0) | ||||||||||||
Foreign derived intangible income benefit | — | (25.1) | ||||||||||||
Restructuring of certain non-U.S. subsidiaries | — | (15.8) | ||||||||||||
Non-deductibility of European Commission fine | — | 11.1 | ||||||||||||
| Other | 2.7 | (2.0) | ||||||||||||
| Effective tax rate | 71.6 | % | (119.8) | % | ||||||||||
(In Millions) | Dec 27, 2025 | Dec 28, 2024 | ||||||||||||
| Deferred tax assets: | ||||||||||||||
| R&D expenditures capitalization | $ | 12,203 | $ | 10,709 | ||||||||||
| State credits and net operating losses | 3,165 | 2,830 | ||||||||||||
| Inventory | 628 | 1,054 | ||||||||||||
| Accrued compensation and other benefits | 921 | 970 | ||||||||||||
| Share-based compensation | 481 | 444 | ||||||||||||
| Litigation charge | 320 | 447 | ||||||||||||
| Other, net | 1,547 | 1,510 | ||||||||||||
| Gross deferred tax assets | 19,265 | 17,964 | ||||||||||||
| Valuation allowance | (16,402) | (13,974) | ||||||||||||
| Total deferred tax assets | 2,863 | 3,990 | ||||||||||||
| Deferred tax liabilities: | ||||||||||||||
Property, plant and equipment | (3,294) | (4,063) | ||||||||||||
| Licenses and intangibles | (466) | (159) | ||||||||||||
| Unrealized gains on investments and derivatives | (168) | (224) | ||||||||||||
| Other, net | (51) | (403) | ||||||||||||
| Total deferred tax liabilities | (3,979) | (4,849) | ||||||||||||
| Net deferred tax assets (liabilities) | $ | (1,116) | $ | (859) | ||||||||||
| Reported as: | ||||||||||||||
| Deferred tax assets | $ | 570 | $ | 603 | ||||||||||
| Deferred tax liabilities | (1,686) | (1,462) | ||||||||||||
| Net deferred tax assets (liabilities) | $ | (1,116) | $ | (859) | ||||||||||
| Years Ended (In Millions) | Dec 27, 2025 | Dec 28, 2024 | Dec 30, 2023 | |||||||||||||||||
Balance at Beginning of Year | $ | 13,974 | $ | 3,047 | $ | 2,586 | ||||||||||||||
Additions charged to expenses/other accounts | 2,428 | 10,927 | 461 | |||||||||||||||||
(Deductions) recoveries, net | — | — | — | |||||||||||||||||
Balance at End of Year | $ | 16,402 | $ | 13,974 | $ | 3,047 | ||||||||||||||
| Years Ended (In Millions) | Dec 27, 2025 | Dec 28, 2024 | Dec 30, 2023 | |||||||||||||||||
| Beginning gross unrecognized tax benefits | $ | 1,130 | $ | 1,124 | $ | 1,229 | ||||||||||||||
| Settlements and effective settlements with tax authorities | (52) | (59) | (288) | |||||||||||||||||
| Changes in balances related to tax position taken during prior periods | 201 | (8) | — | |||||||||||||||||
| Changes in balances related to tax position taken during current period | 105 | 73 | 183 | |||||||||||||||||
| Ending gross unrecognized tax benefits | $ | 1,384 | $ | 1,130 | $ | 1,124 | ||||||||||||||
| Year Ended (In Millions) | Dec 27, 2025 | |||||||
| Federal taxes | $ | 1,393 | ||||||
| State taxes | (7) | |||||||
| Foreign taxes: | ||||||||
| China | 276 | |||||||
| Israel | 197 | |||||||
| Other foreign jurisdictions | 440 | |||||||
| Total cash taxes paid | $ | 2,299 | ||||||
Years Ended (In Millions) | Dec 28, 2024 | Dec 30, 2023 | ||||||||||||
Cash paid during the year for: | ||||||||||||||
Income taxes, net of refunds | $ | 2,202 | $ | 2,621 | ||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Jan 23, 2026 | Showing above |
| 2024 | Jan 31, 2025 | |
| 2023 | Jan 26, 2024 | |
| 2022 | Jan 27, 2023 | |
| 2021 | Jan 27, 2022 | |
| 2020 | Jan 22, 2021 | |
| 2019 | Jan 24, 2020 | |
| 2018 | Feb 1, 2019 | |
| 2017 | Feb 16, 2018 | |
| 2016 | Feb 17, 2017 | |
| 2015 | Feb 12, 2016 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.